+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Preclinical CRO Market by Services (Bioanalysis & DMPK Studies, Toxicology Testing), Application (Cardiovascular Disease, Dermatology, Gastrointestinal), End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 199 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 5454997
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Preclinical CRO Market grew from USD 6.25 billion in 2023 to USD 6.85 billion in 2024. It is expected to continue growing at a CAGR of 9.68%, reaching USD 11.95 billion by 2030.

Preclinical research services encompass several studies critical to assessing drug efficacy & safety in animal models and complete Investigational New Drug (IND) filing studies. In a preclinical trial, CROs are hired by sponsors such as biopharma companies to perform a set of tasks, taking various technical and administrative responsibilities on the sponsor’s behalf. A surge in the number of drugs in the preclinical phase and an increased research & development (R&D) budget for drug development are driving the usage of preclinical CRO services. The high cost and time-consuming process of preclinical CROS services hamper the market growth. Advances in technology, which include high-throughput screening and in silico modeling, enable more efficient and cost-effective preclinical research and are expected to create opportunities for market growth.

Regional Insights

The unprecedented rise in non-communicable diseases among the geriatric population and communicable diseases caused by changing environmental conditions, such as pollution, and insect infestation, create a demand for effective drug development in the healthcare sector, subsequently increasing the need for preclinical CRO services across the Americas, Asia-Pacific, and EMEA. The investments made by the governments of Asia-Pacific to push research and development (R&D) activities of medical devices and drug development are estimated to provide growth opportunities for the preclinical CRO market players. In August 2021, the Australian government invested USD 79 million in medical innovation and research projects. The developed economies in the European Union have established a supportive government framework to boost technological advancements by prioritizing research and innovation of new technologies and drug development. The government introduces several stringent regulations and standards to ensure that the medicines and devices developed are safe, reliable, and of high quality. In January 2022, the Clinical Trials Regulation (Regulation (EU) No 536/2014) was set to launch in the EU to modify the clinical trial processes. The government introduced a Clinical Trials Information System (CTIS) to harmonize the supervision and assessment processes. Thus, the ongoing government support for clinical trials for medical devices and drug development is expected to fuel the growth of the preclinical CRO market in EMEA.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the Preclinical CRO Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Increasing R&D activities by pharmaceutical and biopharmaceutical companies to develop new drugs & therapies
  • Rising trend of outsourcing drug development activities to CROs by pharmaceutical companies
  • Growing focus on the development of personalized medicines

Market Restraints

  • High cost and time-consuming constraints associated with preclinical CRO services

Market Opportunities

  • Growing advances in technologies to enable more efficient and cost-effective preclinical research
  • High potential for preclinical research for biologics, including monoclonal antibodies, vaccines, and cell therapies

Market Challenges

  • Stringent regulations and guidelines set by international regulatory authorities

Market Segmentation Analysis

  • Services: Burgeoning usage of Toxicology testing services focusing on the safety and regulatory compliance aspects
  • End-User: Evolving usage of preclinical CRO by biopharmaceutical companies

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Preclinical CRO Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Preclinical CRO Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

CRO Company TriApex Completes Series C Financing Round Led by Legend Capital

Triapex, a Preclinical CRO and Contract Research Organization (CRO), recently completed a Series C round of financing led by Legend Capital. This investment further strengthens Triapex's place among the top players in the global preclinical CRO market. With this additional funding, Triapex is well-positioned to provide high-quality services to its clients and expand its presence worldwide. The success of this financing round is a testament to Triapex's commitment to providing quality services through innovative methods, making them a preferred partner for many organizations.

PsychoGenics Launches eCube, a New AI-Enabled Platform for Drug Discovery

PsychoGenics Inc., AI-enabled phenotypic drug discovery and preclinical CRO services provider, launched its advanced AI-Enabled Platform, eCube, to enable more efficient and effective preclinical drug discovery in the CRO market. eCube is the first data-driven platform that leverages Natural Language Processing (NLP) and Machine Learning algorithms to expedite the preclinical drug discovery process, which involves a large amount of manual labor. This revolutionary platform has been designed to streamline operations, reduce costs and optimize research timelines for various CROs in the preclinical market. With the help of eCube's comprehensive analytics system, CROs can generate meaningful insights from raw data for better decision-making. The launch of PsychoGenics' eCube marks a new era of innovation in the preclinical drug discovery process and promises to revolutionize the CRO market.

Proscia Announces Major Expansion in Preclinical R&D to Drive Faster Drug Safety Decisions

The preclinical CRO market rapidly expands due to increased demand for drug safety decisions. Proscia recently announced a significant expansion into the preclinical research space, with plans to significantly increase their capabilities and expand their services. This move allows Proscia to continue providing innovative solutions that enable pharmaceutical companies and research institutions to make faster and better decisions about drug safety. With its new technology, such as advanced digital pathology and AI-driven image analysis, Proscia can offer unprecedented scalability, accuracy, and speed in preclinical research. This expansion is an essential step in helping the industry move forward in developing safer drugs with more reliable data.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Preclinical CRO Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Preclinical CRO Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., AmplifyBio, Atuka Inc., BenchSci, Bioserve Biotechnologies (India) PVT Ltd. by REPROCELL Inc., Biotrofix, Inc., Celerion, Charles River Laboratories International, Inc., Crown Bioscience, Inc., CTI Clinical Trial and Consulting, Inc., Diag2Tec SAS, Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Gubra, Hera Biolabs, ICON PLC, Immusmol SAS, ImQuest BioSciences, Inotiv, Inc., Intertek Group PLC, Invivotek by Genesis Biotechnology Group, LLC, IQVIA Inc., Jubilant Biosys Ltd. byJubilant Pharmova Limited Company, Laboratory Corporation of America Holding, MCI Group Holding SA, MD Biosciences, Medpace Holdings, Inc., Novartis AG, Parexel International Corporation., PharmaCircle LLC, Phenos GmbH, PPD by Thermo Fisher Scientific Inc., PsychoGenics Inc., QPS Holdings, LLC, Sanofi S.A., SCiAN Services Inc., SGS SA, Shanghai Medicilon Inc., Syneos Health, Inc., Transpharmation, Veristat, LLC, Vimta Labs Limited, and WuXi AppTec Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Preclinical CRO Market to forecast the revenues and analyze trends in each of the following sub-markets:

Services

  • Bioanalysis & DMPK Studies
  • Toxicology Testing

Application

  • Cardiovascular Disease
  • Dermatology
  • Gastrointestinal
  • Genitourinary & Women’s Health
  • Hematology
  • Immunological Disorders
  • Infectious Diseases
  • Metabolic Disorders
  • Neurology
  • Oncology
  • Ophthalmology
  • Respiratory Disorders

End-User

  • Biopharmaceutical Companies
  • Government & Academic Institutes
  • Medical Device Companies

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing R&D activities by pharmaceutical and biopharmaceutical companies to develop new drugs & therapies
5.1.1.2. Rising trend of outsourcing drug development activities to CROs by pharmaceutical companies
5.1.1.3. Growing focus on the development of personalized medicines
5.1.2. Restraints
5.1.2.1. High cost and time-consuming constraints associated with preclinical CRO services
5.1.3. Opportunities
5.1.3.1. Growing advances in technologies to enable more efficient and cost-effective preclinical research
5.1.3.2. High potential for preclinical research for biologics, including monoclonal antibodies, vaccines, and cell therapies
5.1.4. Challenges
5.1.4.1. Stringent regulations and guidelines set by international regulatory authorities
5.2. Market Segmentation Analysis
5.2.1. Services: Burgeoning usage of Toxicology testing services focusing on the safety and regulatory compliance aspects
5.2.2. End-User: Evolving usage of preclinical CRO by biopharmaceutical companies
5.3. Market Trend Analysis
5.3.1. Presence of well-established pharmaceutical & biopharmaceutical companies and the rising introduction of advanced preclinical CRO platforms in the Americas
5.3.2. Rising government support for expanding research & development activities into developing new drugs and medical devices in the Asia-Pacific region
5.3.3. Potential government funding in drug development activities expands the preclinical CRO business in the EMEA region.
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework Analysis
5.8. Client Customization
6. Preclinical CRO Market, by Services
6.1. Introduction
6.2. Bioanalysis & DMPK Studies
6.3. Toxicology Testing
7. Preclinical CRO Market, by Application
7.1. Introduction
7.2. Cardiovascular Disease
7.3. Dermatology
7.4. Gastrointestinal
7.5. Genitourinary & Women’s Health
7.6. Hematology
7.7. Immunological Disorders
7.8. Infectious Diseases
7.9. Metabolic Disorders
7.10. Neurology
7.11. Oncology
7.12. Ophthalmology
7.13. Respiratory Disorders
8. Preclinical CRO Market, by End-User
8.1. Introduction
8.2. Biopharmaceutical Companies
8.3. Government & Academic Institutes
8.4. Medical Device Companies
9. Americas Preclinical CRO Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Preclinical CRO Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Preclinical CRO Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. CRO Company TriApex Completes Series C Financing Round Led by Legend Capital
12.3.2. PsychoGenics Launches eCube, a New AI-Enabled Platform for Drug Discovery
12.3.3. Proscia Announces Major Expansion in Preclinical R&D to Drive Faster Drug Safety Decisions
12.3.4. AmplifyBio Expands Cell Therapy Characterization, Fills Gap in Preclinical Development
12.3.5. Clinchoice Continues Expansion with CRO Acquisition
12.3.6. ??QPS opens an additional preclinical research facility in Taiwan
12.3.7. CRO Avania Acquires MAXIS
12.3.8. Apax Acquires a Majority Stake in Porsolt to Support its Growth Strategy and Become a Global Leader in Preclinical Services
12.3.9. Cryoport Announces Strategic Partnership with Syneos Health to Advance Cell & Gene Therapies
12.3.10. Crown Bioscience and ERS Genomics Announce Global CRISPR/Cas9 Licensing Agreement for Genome Editing Patents
12.3.11. Domain Therapeutics and Explicyte Enter Partnership Agreement in Immuno-Oncology
12.3.12. Celerion Expands Early Phase Clinical Pharmacology Units
12.3.13. ClinChoice Raises USD 150 Million in Series E Round
12.3.14. Hera BioLabs Announces Exclusive Global License With Charles River
12.3.15. IonsGate Preclinical Services and InSilicoTrials Form Partnership
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. PRECLINICAL CRO MARKET RESEARCH PROCESS
FIGURE 2. PRECLINICAL CRO MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL PRECLINICAL CRO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL PRECLINICAL CRO MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL PRECLINICAL CRO MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. PRECLINICAL CRO MARKET DYNAMICS
FIGURE 7. GLOBAL PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
FIGURE 8. GLOBAL PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PRECLINICAL CRO MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. GLOBAL PRECLINICAL CRO MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. PRECLINICAL CRO MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. PRECLINICAL CRO MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. PRECLINICAL CRO MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL PRECLINICAL CRO MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL PRECLINICAL CRO MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL PRECLINICAL CRO MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL PRECLINICAL CRO MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL PRECLINICAL CRO MARKET SIZE, BY BIOANALYSIS & DMPK STUDIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL PRECLINICAL CRO MARKET SIZE, BY BIOANALYSIS & DMPK STUDIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL PRECLINICAL CRO MARKET SIZE, BY TOXICOLOGY TESTING, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL PRECLINICAL CRO MARKET SIZE, BY TOXICOLOGY TESTING, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL PRECLINICAL CRO MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL PRECLINICAL CRO MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL PRECLINICAL CRO MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL PRECLINICAL CRO MARKET SIZE, BY DERMATOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL PRECLINICAL CRO MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL PRECLINICAL CRO MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL PRECLINICAL CRO MARKET SIZE, BY GENITOURINARY & WOMEN’S HEALTH, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL PRECLINICAL CRO MARKET SIZE, BY GENITOURINARY & WOMEN’S HEALTH, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL PRECLINICAL CRO MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL PRECLINICAL CRO MARKET SIZE, BY HEMATOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL PRECLINICAL CRO MARKET SIZE, BY IMMUNOLOGICAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL PRECLINICAL CRO MARKET SIZE, BY IMMUNOLOGICAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL PRECLINICAL CRO MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL PRECLINICAL CRO MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL PRECLINICAL CRO MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL PRECLINICAL CRO MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL PRECLINICAL CRO MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL PRECLINICAL CRO MARKET SIZE, BY NEUROLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL PRECLINICAL CRO MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL PRECLINICAL CRO MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL PRECLINICAL CRO MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL PRECLINICAL CRO MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL PRECLINICAL CRO MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL PRECLINICAL CRO MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL PRECLINICAL CRO MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL PRECLINICAL CRO MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL PRECLINICAL CRO MARKET SIZE, BY GOVERNMENT & ACADEMIC INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL PRECLINICAL CRO MARKET SIZE, BY GOVERNMENT & ACADEMIC INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL PRECLINICAL CRO MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL PRECLINICAL CRO MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. AMERICAS PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 48. AMERICAS PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 49. AMERICAS PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 50. AMERICAS PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 51. AMERICAS PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 52. AMERICAS PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 53. AMERICAS PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 54. AMERICAS PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 55. ARGENTINA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 56. ARGENTINA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 57. ARGENTINA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 58. ARGENTINA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 59. ARGENTINA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 60. ARGENTINA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 61. BRAZIL PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 62. BRAZIL PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 63. BRAZIL PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 64. BRAZIL PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 65. BRAZIL PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 66. BRAZIL PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 67. CANADA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 68. CANADA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 69. CANADA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 70. CANADA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 71. CANADA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 72. CANADA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 73. MEXICO PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 74. MEXICO PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 75. MEXICO PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 76. MEXICO PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 77. MEXICO PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 78. MEXICO PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 79. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 80. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 81. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 82. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 83. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 84. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 85. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 86. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 87. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 88. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 89. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 90. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 92. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 94. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 95. AUSTRALIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 96. AUSTRALIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 97. AUSTRALIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 98. AUSTRALIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 99. AUSTRALIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 100. AUSTRALIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 101. CHINA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 102. CHINA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 103. CHINA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 104. CHINA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 105. CHINA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 106. CHINA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 107. INDIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 108. INDIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 109. INDIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 110. INDIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 111. INDIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 112. INDIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 113. INDONESIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 114. INDONESIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 115. INDONESIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 116. INDONESIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 117. INDONESIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 118. INDONESIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 119. JAPAN PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 120. JAPAN PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 121. JAPAN PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 122. JAPAN PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 123. JAPAN PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 124. JAPAN PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 125. MALAYSIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 126. MALAYSIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 127. MALAYSIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 128. MALAYSIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 129. MALAYSIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 130. MALAYSIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 131. PHILIPPINES PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 132. PHILIPPINES PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 133. PHILIPPINES PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 134. PHILIPPINES PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 135. PHILIPPINES PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 136. PHILIPPINES PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 137. SINGAPORE PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 138. SINGAPORE PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 139. SINGAPORE PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 140. SINGAPORE PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 141. SINGAPORE PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 142. SINGAPORE PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 143. SOUTH KOREA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 144. SOUTH KOREA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 145. SOUTH KOREA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 146. SOUTH KOREA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 147. SOUTH KOREA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 148. SOUTH KOREA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 149. TAIWAN PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 150. TAIWAN PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 151. TAIWAN PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 152. TAIWAN PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 153. TAIWAN PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 154. TAIWAN PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 155. THAILAND PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 156. THAILAND PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 157. THAILAND PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 158. THAILAND PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 159. THAILAND PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 160. THAILAND PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 161. VIETNAM PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 162. VIETNAM PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 163. VIETNAM PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 164. VIETNAM PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 165. VIETNAM PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 166. VIETNAM PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 175. DENMARK PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 176. DENMARK PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 177. DENMARK PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 178. DENMARK PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 179. DENMARK PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 180. DENMARK PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 181. EGYPT PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 182. EGYPT PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 183. EGYPT PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 184. EGYPT PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 185. EGYPT PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 186. EGYPT PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 187. FINLAND PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 188. FINLAND PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 189. FINLAND PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 190. FINLAND PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 191. FINLAND PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 192. FINLAND PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 193. FRANCE PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 194. FRANCE PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 195. FRANCE PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 196. FRANCE PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 197. FRANCE PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 198. FRANCE PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 199. GERMANY PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 200. GERMANY PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 201. GERMANY PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 202. GERMANY PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 203. GERMANY PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 204. GERMANY PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 205. ISRAEL PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 206. ISRAEL PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 207. ISRAEL PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 208. ISRAEL PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 209. ISRAEL PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 210. ISRAEL PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 211. ITALY PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 212. ITALY PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 213. ITALY PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 214. ITALY PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 215. ITALY PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 216. ITALY PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 217. NETHERLANDS PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 218. NETHERLANDS PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 219. NETHERLANDS PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 220. NETHERLANDS PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 221. NETHERLANDS PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 222. NETHERLANDS PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 223. NIGERIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 224. NIGERIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 225. NIGERIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 226. NIGERIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 227. NIGERIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 228. NIGERIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 229. NORWAY PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 230. NORWAY PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 231. NORWAY PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 232. NORWAY PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 233. NORWAY PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 234. NORWAY PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 235. POLAND PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 236. POLAND PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 237. POLAND PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 238. POLAND PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 239. POLAND PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 240. POLAND PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 241. QATAR PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 242. QATAR PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 243. QATAR PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 244. QATAR PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 245. QATAR PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 246. QATAR PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 247. RUSSIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 248. RUSSIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 249. RUSSIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 250. RUSSIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 251. RUSSIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 252. RUSSIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 253. SAUDI ARABIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 254. SAUDI ARABIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 255. SAUDI ARABIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 256. SAUDI ARABIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 257. SAUDI ARABIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 258. SAUDI ARABIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 259. SOUTH AFRICA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 260. SOUTH AFRICA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 261. SOUTH AFRICA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 262. SOUTH AFRICA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 263. SOUTH AFRICA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 264. SOUTH AFRICA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 265. SPAIN PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 266. SPAIN PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 267. SPAIN PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 268. SPAIN PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 269. SPAIN PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 270. SPAIN PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 271. SWEDEN PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 272. SWEDEN PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 273. SWEDEN PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 274. SWEDEN PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 275. SWEDEN PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 276. SWEDEN PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 277. SWITZERLAND PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 278. SWITZERLAND PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 279. SWITZERLAND PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 280. SWITZERLAND PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 281. SWITZERLAND PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 282. SWITZERLAND PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 283. TURKEY PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 284. TURKEY PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 285. TURKEY PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 286. TURKEY PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 287. TURKEY PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 288. TURKEY PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 295. UNITED KINGDOM PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 296. UNITED KINGDOM PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 297. UNITED KINGDOM PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 298. UNITED KINGDOM PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 299. UNITED KINGDOM PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 300. UNITED KINGDOM PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 301. PRECLINICAL CRO MARKET SHARE, BY KEY PLAYER, 2023
TABLE 302. PRECLINICAL CRO MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

  • 10x Genomics, Inc.
  • AmplifyBio
  • Atuka Inc.
  • BenchSci
  • Bioserve Biotechnologies (India) PVT Ltd. by REPROCELL Inc.
  • Biotrofix, Inc.
  • Celerion
  • Charles River Laboratories International, Inc.
  • Crown Bioscience, Inc.
  • CTI Clinical Trial and Consulting, Inc.
  • Diag2Tec SAS
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd.
  • Gubra
  • Hera Biolabs
  • ICON PLC
  • Immusmol SAS
  • ImQuest BioSciences
  • Inotiv, Inc.
  • Intertek Group PLC
  • Invivotek by Genesis Biotechnology Group, LLC
  • IQVIA Inc.
  • Jubilant Biosys Ltd. byJubilant Pharmova Limited Company
  • Laboratory Corporation of America Holding
  • MCI Group Holding SA
  • MD Biosciences
  • Medpace Holdings, Inc.
  • Novartis AG
  • Parexel International Corporation.
  • PharmaCircle LLC
  • Phenos GmbH
  • PPD by Thermo Fisher Scientific Inc.
  • PsychoGenics Inc.
  • QPS Holdings, LLC
  • Sanofi S.A.
  • SCiAN Services Inc.
  • SGS SA
  • Shanghai Medicilon Inc.
  • Syneos Health, Inc.
  • Transpharmation
  • Veristat, LLC
  • Vimta Labs Limited
  • WuXi AppTec Co., Ltd.

Methodology

Loading
LOADING...

Table Information